Hema Priyadarshini Patnaik

Hema Priyadarshini Patnaik, Senior Associate, JSA

Hema specialises in General Corporate and her practice covers Corporate Commercial, Corporate Restructuring, Mergers & Acquisitions and Private Equity investments.

She has extensive experience in Corporate Commercial and transactions including Private Equity, Foreign Investment, Joint Ventures and Acquisitions across industry sectors.

She has been practicing law since 2014. Before joining JSA, she was with Desai & Diwanji, one of India’s premier and oldest law firms for three and half years.

Her work experience includes advising on acquisitions and private equity investments in India, and on various issues arising out of the exchange control laws, Companies Act, and sector specific laws.

 

Memberships

Bar Council of Delhi

 

Education

B.B.A LL.B(Hons.), National Law University Odisha, Cuttack

 

Languages

  • English
  • Hindi
  • Oriya

Some of the key assignments in these areas handled and being handled by Hema amongst others, cover the following :-

  • Advised and assisted Tiger Global and Ribbit Capital in the sale of a portion of their existing shareholding in Etechaces Marketing and Consulting Private Limited (“Etechaces”) held by them to Softbank group, Tencent and Steadview Capital.
  • Advised Air Water Inc., Japan and Air Water India Private Limited in the acquisition of business undertaking engaged in the manufacturing, distributing and selling specialty industrial gases, from Linde India Limited.
  • Advised Affirma Capital (earlier Standard Chartered Private Equity) in the acquisition of significant minority stake in the share capital of Tirupati Medicare Limited by TBO Korea Holdings Limited (an affiliate of Affirma Capital).
  • Advised Omax Autos Limited in its sale of identified assets (including movables and immovables) to Hema Engineering Industries Limited (“Hema Engineering“) by way of an asset purchase agreement.
  • Advised Naspers Ventures BV (Naspers) in the Indian leg of the transaction wherein Naspers participated along with other investors in the Series D funding round of Meesho.
  • Advised Tiger Global on its investment of approximately INR 1,000,000,000 (Rupees One Billion) in Open Financial Technologies Private Limited.
  • Advised Nature’s Essence Private Limited, Nature’s Organics and Magikle Pharma Private Limited (“Nature’s Group”) in the acquisition of Nature’s Group by Samara Alternate Investment Fund.
  • Advised and assisted Mastercard International Inc. (Mastercard) in connection with the Indian leg of 100% share acquisition of Trans-Fast Remittance Inc.
  • Advised the promoters of Ban Labs Private Limited (“BLPL”) in relation to the sale of the business undertaking engaged in manufacture of haircare products (under the brand name Sesa) to a True North (a private equity fund) entity.
  • Advised Avaana Capital Growth Fund I in its investment in Glitterbug Technologies Private Limited.
  • Advised Glitterbug Technologies Private Limited (Glitterbug) with respect to its internal restructuring and appointment of Avaana Capital Growth Fund I and Transamerica Ventures Fund, LLC as interim managers of Glitterbug.
  • Advised Redpine Signals Inc. (Redpine) with respect to India leg of the transaction which involved sale of assets (including assets of Redpine’s subsidiary in India) to Silicon Laboratories Inc. and its subsidiary in India, Swarushi Technologies Private Limited.
  • Advised and represented Judges Scientific PLC with respect to the India leg of its acquisition of Heath Scientific Company Limited (HSCL). HSCL has a joint venture company in India (KAN THT) with Kagaku Analys Aktiebolag, a Swedish company. Pursuant to the transaction, Judges indirectly holds 50% of KAN THT through HSCL.